You are here

Policy

 

Specialists agree that having either a family history of breast cancer or dense breast tissue puts patients at a greater risk of developing breast cancer. Where disagreement persists, however, is what exactly to do with that information. Some experts believe that providers should implement risk-based mammographic screening for breast cancer, but according to a new study published in the American Journal of Roentgenology, such a system could delay the detection and treatment of a large number of cancers.

Medical Imaging Still Seeing Its Fair Share of Breakthroughs 

Thirty-two states enacted breast density reporting legislation in the last eight years, but no such bills have been passed on a federal level. Could that soon change?

Temperatures are dropping and my front yard is covered in leaves, which means it’s almost time for another eventful RSNA annual meeting in Chicago. I’ve spent some with this year’s schedule and wanted to share five can’t-miss sessions.

Women should not stop undergoing regular mammography based on their age alone, according to a new analysis published by the American Journal of Roentgenology. The authors of the article explored both the benefits and the risks of screening mammography for women ages 75 years and older.

 

Recent Headlines

USPSTF reinforces recommendation against thyroid cancer screening

The USPSTF recommends against thyroid screening in asymptomatic adults, issuing guidance on a “D” rating (recommends against screening). 

Senate repeal-and-replace bill could improve on imaging-related policy

The U.S. House of Representatives passed the controversial American Health Care Act (AHCA) by a narrow vote, but any and all parts of the bill are up for debate in the Senate—including the provision allowing states to waive requirements for essential health benefits such as preventative screening.

House passes ACA replacement—with potential to reduce screening

The U.S. House of Representatives passed a bill to repeal and replace the Affordable Care Act (ACA) by a narrow vote, sending the American Health Care Act (AHCA) to the Senate for the next stage in a pitched legislative battle.

NIH scientists to be limited on grant support

The U.S. National Institutes of Health (NIH) announced May 2 that a new policy will be put in place to restrict the amount of funding an individual scientist can hold at any one time by using a point-based system.

Samsung continues foray into diagnostic imaging with radiography unit

Samsung is adding a new digital radiography unit to its growing roster of medical imaging equipment, receiving FDA 501(k) approval for the GC70 Digital Radiography system.

RBMA PaRADigm 2017: Ben Wanamaker on some of healthcare's biggest issues—and how to fix them

Healthcare is in desperate need of a change, Ben Wanamaker explained during his keynote address Monday morning at RBMA PaRADigm 2017 in Chicago. Consumer costs are on the rise, pricing for basic services is widely inconsistent and the government is spending more and more tax dollars on policies such as social security, Medicare and Medicaid. 

Radiology should work with certified health records—not against them

Radiologists should understand the importance of using certified electronic health record (EHR) technology—now more than ever with the opening of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)’s first reporting period.

As Policies Evolve, Practice Leadership Must Remain Active

As research director of a policy think tank dedicated to medical imaging, I’m frequently asked how radiologists—and their practices—will fit into the broader healthcare landscape once the current tumultuous healthcare environment evolves into stable equilibrium. Of course, whether we do see a stable equilibrium is a questionable assumption in itself, but it doesn’t hurt to put on our futurist hats and explore how this may look for radiology. 

FDA approves first digital pathology system for diagnostic use

Royal Phillips has received U.S. Food and Drug Administration (FDA) clearance for its IntelliSite Pathology Solution, a pathology image creation and management system. Its currently the only digital pathology system cleared for primary diagnostic use, an important milestone in the burgeoning field.

USPSTF changes 2012 recommendation on PSA testing

Blood testing for prostate cancer now has a passing grade—the U.S. Preventative Services Task Force (USPSTF) has changed its tune on prostate-specific antigen (PSA) screening, upgrading the recommendation that some men undergo to a “C” grade.  

Pages